Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach
Open Access
- 29 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e72088
Abstract
The development of high-risk human papillomavirus (hrHPV) infection to cervical cancer is a complicated process. We considered solely hrHPV infections, thus avoiding the confounding effects of disease progression, screening, and treatments. To analyse hrHPV epidemiology and to estimate the overall impact of vaccination against infections with hrHPVs, we developed a dynamic compartmental transmission model for single and multiple infections with 14 hrHPV types. The infection-related parameters were estimated using population-based sexual behaviour and hrHPV prevalence data from Finland. The analysis disclosed the important role of persistent infections in hrHPV epidemiology, provided further evidence for a significant natural immunity, and demonstrated the dependence of transmission probability estimates on the model structure. The model predicted that vaccinating girls at 80% coverage will result in a 55% reduction in the overall hrHPV prevalence and a higher 65% reduction in the prevalence of persistent hrHPV infections in females. In males, the reduction will be 42% in the hrHPV prevalence solely by the herd effect from the 80% coverage in girls. If such high coverage among girls is not reached, it is still possible to reduce the female hrHPV prevalence indirectly by the herd effect if also boys are included in the vaccination program. On the other hand, any herd effects in older unvaccinated cohorts were minor. Limiting the epidemiological model to infection yielded improved understanding of the hrHPV epidemiology and of mechanisms with which vaccination impacts on hrHPV infections.Keywords
This publication has 28 references indexed in Scilit:
- Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based AnalysisJNCI: Journal of the National Cancer Institute, 2012
- Occurrence of vaccine and non‐vaccine human papillomavirus types in adolescent Finnish females 4 years post‐vaccinationInternational Journal of Cancer, 2012
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 YearsThe Journal of Infectious Diseases, 2009
- A Multi-Type HPV Transmission ModelBulletin of Mathematical Biology, 2008
- Prevalence of oncogenic human papillomavirus infection in an organised screening population in FinlandInternational Journal of Cancer, 2008
- High-risk HPV type-specific clearance rates in cervical screeningBritish Journal of Cancer, 2007
- Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling AnalysesPLOS Medicine, 2006
- Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in FinlandJournal of General Virology, 2003
- The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus VaccineEpidemiology, 2002
- Sexual Network Structure and Sexually Transmitted Disease PreventionSexually Transmitted Diseases, 2000